Structural Formula (Image 01)
Nexium Capsule, Delayed Release
Product Images NDC 0186-5020
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Nexium (NDC 0186-5020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 Maintenance Of Healing Rates By Month (study 117) (Image 02)
Figure 3 Maintenance Of Healing Rates By Mondy (study 178) (Image 03)
The text is not available as it is just some numbers and partial words that don't make sense.*
Figure 4 Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Image 04)
Figure 5 Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Image 05)
The given text "Percent of Patients Symptom-Free" suggests that the subsequent numbers represent the percentage of patients who are symptom-free. Therefore, the first number "100" might indicate that all patients are symptom-free. However, since there is no further context, it is not clear what kind of symptoms are being referred to, or what population is being studied. The remaining numbers "21" and "28" may be percentages representing the proportion of patients who are symptom-free in different groups or at different time points. Further information is required to give a more accurate interpretation.*
Nexium 20 mg (30 Delayed-Release Capsules)
Nexium 40 mg (30 Delayed-Release Capsules)
Image 08
Image 09
Nexium 2.5 mg (30 Single Dose Granular Packet, for Delayed-Release Oral Suspension)
Nexium is a delayed-release oral suspension medication that comes in child-resistant packets containing 10 mg of esomeprazole magnesium. Each carton has 30 packets, with a total of 30 single-dose packets per carton. The enclosed medication guide should be given to each patient. This product is available only with a prescription.*
Nexium 5 mg (30 Single Dose Granular Packet, for Delayed-Release Oral Suspension)
Nexium is a medication that comes in child-resistant packets and is taken as delayed-release oral suspension. Each packet of the medication has 20mg of esomeprazole magnesium. The medication guide should be given to each patient who is prescribed Nexium. The National Drug Code for the medication is 0186-4020-01.*
Nexium 10 mg (30 Single Dose Granular Packet, for Delayed-Release Oral Suspension)
This text is a label of a medication containing the drug Nexium (esomeprazole magnesium), which is a delayed-release oral suspension presented in packs of 30 sachets. The label also includes a prescription code and instructions to dispense the enclosed Medication Guide to each patient.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
